---
title: "PegBio Co., Ltd. (02565.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02565.HK.md"
symbol: "02565.HK"
name: "PegBio Co., Ltd."
industry: "Biotechnology"
---

# PegBio Co., Ltd. (02565.HK)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | HK Market |
| Website | [www.pegbio.com](https://www.pegbio.com) |

## Company Profile

PegBio Co., Ltd., a biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China. Its products include PB-119, a glucagon like peptide 1 receptor agonist for the treatment of type 2 diabetes mellitus and obesity. The company’s PB-718 that is in b/IIa ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -101.56 | 65/70 | - | - | - |
| PB | 88.11 | 60/70 | 98.73 | 84.75 | 70.95 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 63.05 |
| Highest Target | 101.80 |
| Lowest Target | 101.80 |

## References

- [Company Overview](https://longbridge.com/en/quote/02565.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02565.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02565.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.